We are pleased to announce the inclusion of the first two patients in the TACTIC study.
The first patient was enrolled by Prof Alaide Chieffo from Ospedale San Raffaele, Milan, followed by a second inclusion by Dr Mario Iannaccone from San Giovanni Bosco Hospital, Turin.
TACTIC study is an Investigator Initiated Study funded by Penumbra Inc. which aims to evaluate microvascular obstruction assessed by CMR at 3–5 days post-procedure, with a target enrolment of 140 patients.
This marks an important milestone and a strong start for the study.
🔗 Learn more about the TACTIC study:
TACTIC Study - Structural Heart Disease
CERC. Smart trials. Strong results.
